• Amir Qaseem, Rebecca A Andrews, Karen Campos, Caroline L Goldzweig, Scott MacDonald, Robert M McLean, Rhea E Powell, Nick Fitterman, Performance Measurement Committee of the American College of Physicians, Peter Basch, Elisa Choi, Roger Chou, Charles J Hamori, and Cristin A Mount.
• American College of Physicians, Philadelphia, Pennsylvania (A.Q., K.C.).
• Ann. Intern. Med. 2024 Apr 1; 177 (4): 507513507-513.

AbstractMajor depressive disorder (MDD) is a severe mood disorder that affects at least 8.4% of the adult population in the United States. Characteristics of MDD include persistent sadness, diminished interest in daily activities, and a state of hopelessness. The illness may progress quickly and have devastating consequences if left untreated. Eight performance measures are available to evaluate screening, diagnosis, and successful management of MDD. However, many performance measures do not meet the criteria for validity, reliability, evidence, and meaningfulness. The American College of Physicians (ACP) embraces performance measurement as a means to externally validate the quality of care of practices, medical groups, and health plans and to drive reimbursement processes. However, a plethora of performance measures that provide low or no value to patient care have inundated physicians, practices, and systems and burdened them with collecting and reporting of data. The ACP's Performance Measurement Committee (PMC) reviews performance measures using a validated process to inform regulatory and accreditation bodies in an effort to recognize high-quality performance measures, address gaps and areas for improvement in performance measures, and help reduce reporting burden. Out of 8 performance measures, the PMC found only 1 measure (suicide risk assessment) that was valid at all levels of attribution. This paper presents a review of MDD performance measures and highlights opportunities to improve performance measures addressing MDD management.

22 keywords...

hide…